Kyprolis (carfilzomib)

pCPA File Number: 21707
Negotiation Status:
Concluded with an LOI
Indication(s):
Treatment of multiple myeloma (including relapsed)
Sponsor/Manufacturer:
Amgen Canada Inc.
CDA-AMC Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Negotiation Process Concluded: